Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Radiother Oncol ; 192: 110109, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38280437

RESUMEN

This pilot study reveals a higher prevalence of obstructive sleep apnea syndrome (OSAS) in patients treated for oropharyngeal squamous cell carcinoma with radiotherapy compared to the general population. OSAS indicators such as the Epworth Sleepiness Scale seem insufficient in the diagnostic approach to OSAS in this population and systematic screenings should be considered.


Asunto(s)
Neoplasias Orofaríngeas , Apnea Obstructiva del Sueño , Humanos , Proyectos Piloto , Polisomnografía , Apnea Obstructiva del Sueño/epidemiología , Apnea Obstructiva del Sueño/etiología , Apnea Obstructiva del Sueño/diagnóstico , Neoplasias Orofaríngeas/radioterapia
2.
Am J Rhinol Allergy ; 34(5): 686-693, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32527141

RESUMEN

BACKGROUND: Covid-19 is defined by an association of multiple symptoms, including frequently reported olfactory and gustatory disorders. OBJECTIVE: The main purpose of this study was to analyze the prevalence of these neurosensory impairments in patients with Covid-19, and to assess short-term recovery. METHODS: We performed a multicenter case series study during the Covid-19 epidemic. All patients presenting a RT-PCR-confirmed SARS-CoV-2 infection were included, whether hospitalized or treated at home. To analyze the prevalence and features of olfactory and gustatory dysfunctions, a phone interview was conducted 5 days after the positive PCR result. The questionnaire was submitted again 10 days later to patients having reported olfactory and gustatory disorders, in order to assess their recovery. RESULTS: 115 patients were included in our study. 81 patients (70%) reported olfactory and gustatory disorders without nasal obstruction or rhinorrhea. These impairments were more frequently reported in the female population, young people, and house-bound patients with mild symptomatic forms. Short-term recovery assessed at Day 15 was complete for 64% of the patients, and incomplete in 33%. Median recovery time was 15 days (4-27 days) after olfactory or gustatory symptom onset. CONCLUSION: Olfactory and gustatory dysfunctions related to Covid-19 are frequently reported and prevalent in mild symptomatic forms of the disease. Recovery in most cases seems rapid and complete.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/complicaciones , Trastornos del Olfato/fisiopatología , Percepción Olfatoria/fisiología , Neumonía Viral/complicaciones , Recuperación de la Función , Trastornos del Gusto/fisiopatología , Percepción del Gusto/fisiología , Adulto , Anciano , Anciano de 80 o más Años , COVID-19 , Infecciones por Coronavirus/fisiopatología , Femenino , Estudios de Seguimiento , Francia/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Trastornos del Olfato/etiología , Pandemias , Neumonía Viral/fisiopatología , Prevalencia , Estudios Prospectivos , SARS-CoV-2 , Trastornos del Gusto/epidemiología , Trastornos del Gusto/etiología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA